Migraine: discovery of a specific gene
The discovery of a "gene of migraine" could lead to the development of new treatments . A hope for the millions of people suffering from this ailment around the world.
Migraine affects one in eight people and is considered one of the most debilitating common diseases of our society. Unfortunately, the treatments offered are not effective in all those suffering from these terrible headaches.
A team of scientists from many countries gathered at the Wellcome Trust Sanger Institute in Cambridge to study the problem of migraine from a genetic point of view. In migraine patients, researchers have observed a genetic defect that, during seizures, activated glutamate, a neurotransmitter.
This discovery will explore new therapeutic avenues. We think particularly of a treatment capable of stopping the activity of glutamate and therefore, migraine.